Loading provider…
Loading provider…
Hematology & Oncology Physician in Atlanta, GA
NPI: 1174787352Primary Practice Location
GRADY MEMORIAL HOSPITAL
80 Jesse Hill Jr Dr Se, Atlanta, GA
Primary Employer
Emory Medical Care Foundation
emoryhealthcare.org
HQ Phone
Get M.D. Fuad's Phone Numberphone_androidMobile
Get M.D. Fuad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
GA State Medical License
2013 - 2027
MO State Medical License
2008 - 2011

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
SSM Health/Saint Louis University School of Medicine
Residency • Internal Medicine
2008 - 2011
American University of Beirut Faculty of Medicine
Medical School
Until 2006
Emory School of Medicine
med.emory.edu
Fellowship • Hematology and Medical Oncology
2011 - 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 19 | 44 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 14 | 20 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 24 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 20 |
Authors: Marcus Carden, Andres Chang, Satheesh Chonat, Ross Fasano
Journal: Transfusion
Publication Date: 2019-03-08
Authors: Kong, Jee Hyun, Winton, Elliott F, Heffner, Leonard T, Chen, Zhengjia, Langston, Amelia A, Hill, Brittany, Arellano, Martha, El-Rassi, Fuad, Kim, Audrey, Jillella, Anand, Kota, Vamsi K, Bodó, Imre, Khoury, Hanna Jean
Journal: Cancer
Publication Date: 2017-02-27
Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
Authors: Fuad El Rassi, Hanna Jean Khoury
Publication Date: 2013-08
Lead Sponsor: Afimmune
Intervention / Treatment: DRUG: Epeleuton
Lead Sponsor: Pfizer
Intervention / Treatment: DRUG: Osivelotor
Lead Sponsor: Forma Therapeutics, Inc.
Collaborators: Novo Nordisk A/S
Intervention / Treatment: DRUG: Etavopivat Tablets, DRUG: Etavopivat Tablets Low dose, DRUG: Etavopivat Tablets High dose, DRUG: Placebo Tablets